Biocon Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

Biocon has announced a board meeting where it approved the consolidated financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs. 3,941.9 Cr and a net profit of Rs. 89.2 Cr. The board also proposed a final dividend of Rs. 0.50 per equity share.

Additionally, the company successfully raised Rs. 4,500 Cr through a Qualified Institutional Placement (QIP) during the quarter. A significant portion of these proceeds, Rs. 1,698 Cr, was utilized to acquire Optionally Convertible Debentures (OCDs) issued by its subsidiary, Biocon Biologics Limited (BBL), from Goldman Sachs.